SEC Form 4 · accession 0001127602-18-014146
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John C Martin
Director
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 7:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2018 | M | 50,000 | $23.60 | A | 3,067,762 | D | |
| Common StockF3 | Apr 2, 2018 | S | 26,258 | $72.5099 | D | 3,041,504 | D | |
| Common StockF4 | Apr 2, 2018 | S | 13,080 | $73.3861 | D | 3,028,424 | D | |
| Common StockF5 | Apr 2, 2018 | S | 9,962 | $74.3291 | D | 3,018,462 | D | |
| Common StockF6 | Apr 2, 2018 | S | 700 | $74.9771 | D | 3,017,762 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $23.60 | Apr 2, 2018 | M | 50,000 | D | — | Jan 21, 2019 | Common Stock | 50,000 | 400,000 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $71.90 to $72.90. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $72.91 to $73.91. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $73.92 to $74.90. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $74.93 to $75.05. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.